IJMPD | The role of genetic factors in Hypertension among Iraqi citizens

Indexing and Abstracting

The role of genetic factors in Hypertension among Iraqi citizens

Khaleel Ibrahim Ismael , Suhair Sadai Mahmood , Abbas Abdul Wahhab Jumaah , Ban Thabit Saeed , Luai Farhan Zghair

International Journal of Medical, Pharmacy and Drug Research(IJMPD), Vol-6,Issue-6, November - December 2022, Pages 1-5 , 10.22161/ijmpd.6.6.1

Download | Downloads : 8 | Total View : 585

Article Info: Received: 11 Oct 2022; Received in revised form: 25 Oct 2022; Accepted: 03 Nov 2022; Available online: 10 Nov 2022

Abstract:

In this study, 140 patients were collected, and they were divided into two groups (120 patients and 30 control groups). The average age in this study ranged from 25 to 65 years. This paper aims to know the role of genetic factors in hypertension among Iraqi citizens and. This study was designed through cooperation with the hospital for the purpose of withdrawing the information found in the electronic record to patients, which includes primary information from demographic data (age - gender - body mass index - blood samples - smoking - alcohol - clinical history - genetic history and blood pressure. The data and demographic information related to the patients were analysed by relying on the statistical analysis program IBM soft SPSS 22. The results that were found were a collection of 140 patients (no positive result for 30 patients) (and 120 patients with a positive result), and the statistical value and the mean for the age of the patients was 45.2±15.3 as was done. Proportion of Family History with Hypertension patients and patient distribution (parents for 90 patients with 64.2% - siblings for 28 patients with 20% - offspring for 32 patients with 22.8%. Through the statistical analysis, a statistically significant relationship was found between genetic factors and their effect on arterial hypertension, with a p-value of 0.001.

Keywords:

Arterial, Hypertension, Patients, Genetic, Family History, BMI.

References:

[1] Daniil G, Fernandes-Rosa FL, Chemin J, Blesneac I, Beltrand J, Polak M, et al. CACNA1H mutations are associated with different forms of primary aldosteronism. EBioMedicine (2016) 13:225–36. 10.1016/j.ebiom.2016.10.002 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
[2] Wilson RC, Krozowski ZS, Li K, Obeyesekere VR, Razzaghy-Azar M, Harbison MD, et al. A mutation in the HSD11B2 gene in a family with apparent mineralocorticoid excess. J Clin Endocrinol Metab (1995) 80:2263–6. 10.1210/jcem.80.7.7608290 [PubMed] [CrossRef] [Google Scholar]
[3] Simonetti GD, Mohaupt MG, Bianchetti MG. Monogenic forms of hypertension. Eur J Pediatr (2012) 171:1433–9. 10.1007/s00431-011-1440-7 [PubMed] [CrossRef] [Google Scholar]
[4] Morineau G, Sulmont V, Salomon R, Fiquet-Kempf B, Jeunemaître X, Nicod J, et al. Apparent mineralocorticoid excess: report of six new cases and extensive personal experience. J Am Soc Nephrol (2006) 17:3176–84. 10.1681/ASN.2006060570 [PubMed] [CrossRef] [Google Scholar]
[5] Lavery GG, Ronconi V, Draper N, Rabbitt EH, Lyons V, Chapman KE, et al. Late-onset apparent mineralocorticoid excess caused by novel compound heterozygous mutations in the HSD11B2 gene. Hypertension (2003) 42:123–9. 10.1161/01.HYP.0000083340.57063.35 [PubMed] [CrossRef] [Google Scholar]
[6] Geller DS, Farhi A, Pinkerton N, Fradley M, Moritz M, Spitzer A, et al. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science (2000) 289:119–23. 10.1126/science.289.5476.119 [PubMed] [CrossRef] [Google Scholar]
[7] White PC, Curnow KM, Pascoe L. Disorders of steroid 11 beta-hydroxylase isozymes. Endocr Rev (1994) 15:421–38. 10.1210/edrv-15-4-421 [PubMed] [CrossRef] [Google Scholar]
[8] Rossier BC, Schild L. Epithelial sodium channel: Mendelian versus essential hypertension. Hypertension (2008) 52:595–600. 10.1161/HYPERTENSIONAHA.107.097147 [PubMed] [CrossRef] [Google Scholar]
[9] Yang C-L, Zhu X, Wang Z, Subramanya AR, Ellison DH. Mechanisms of WNK1 and WNK4 interaction in the regulation of thiazide-sensitive NaCl cotransport. J Clin Invest (2005) 115:1379–87. 10.1172/JCI22452 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
[10] Kahle KT, Ring AM, Lifton RP. Molecular physiology of the WNK kinases. Annu Rev Physiol (2008) 70:329–55. 10.1146/annurev.physiol.70.113006.100651 [PubMed] [CrossRef] [Google Scholar]
[11] Gordon RD. Syndrome of hypertension and hyperkalemia with normal glomerular filtration rate. Hypertension (1986) 8:93–102. [PubMed] [Google Scholar]
[12] Manning AK, LaValley M, Liu C-T, et al. Meta-analysis of Gene-Environment interaction: joint estimation of SNP and SNP×Environment regression coefficients. Genetic Epidemiology. 2011;35 (1):11–18. doi: 10.1002/gepi.20546. This paper lays the foundation for meta-analytic procedures for genome-wide association studies to investigate gene-environment interactions with a working application in type 2 diabetes research. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
[13] Thomas D. Gene-Environment-Wide Association Studies: Emerging Approaches. Nature reviews Genetics. 2010;11 (4):259–272. doi: 10.1038/nrg2764. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
[14] Cox D. Interaction. International Statistical Review/Revue Internationale De Statistique. 1984;52 (1):1–24. http://www.jstor.org/stable/1403235. [Google Scholar]
[15] Ottman R. An Epidemiologic Approach to Gene-Environment Interaction. Genetic epidemiology. 1990;7 (3):177. doi: 10.1002/gepi.1370070302. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
[16] Hunter DJ. Gene-environment interactions in human diseases. Nat Rev Genet. 2005; 6:287–98. doi: 10.1038/nrg1578. [PubMed] [CrossRef] [Google Scholar]
[17] Engelman CD, Baurley JW, Chiu Y-F, et al. Detecting Gene-Environment Interactions in Genome-Wide Association Data. Genetic Epidemiology. 2009;33(Suppl 1):68–73. doi: 10.1002/gepi.20475. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
[18] Goldman D, Oroszi G, Ducci F. The genetics of addictions: uncovering the genes. Nature Reviews Genetics. 2005; 6:521–532. [PubMed] [Google Scholar]
[19] Dudbridge F, Fletcher O. Gene-Environment Dependence Creates Spurious Gene-Environment Interaction. American Journal of Human Genetics. 2014;95 (3):301–307. doi: 10.1016/j.ajhg.2014.07.014. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
[20] García-Closas M, Thompson WD, Robins JM. Differential misclassification and the assessment of gene-environment interactions in case-control studies. Am J Epidemiol. 1998; 1475:426–433. [PubMed] [Google Scholar]
[21] Hein R, Beckmann L, Chang-Claude J. Sample size requirements for indirect association studies of gene-environment interactions (G × E) Genet Epidemiol. 2008; 32:235–245. [PubMed] [Google Scholar]
[22] Devlin B, Roeder K. Genomic Control for Association Studies. Biometrics. 1999;55(4):997–1004. doi: 10.1111/j.0006-341X.1999.00997. x. [PubMed] [CrossRef] [Google Scholar]
[23] Ioannidis JP, Trikalinos TA, Khoury MJ. Implications of small effect sizes of individual genetic variants on the design and interpretation of genetic association studies of complex diseases. Am J Epidemiol. 2006; 164:609–614. [PubMed] [Google Scholar]
[24] Becker BJ, Wu M-J. The Synthesis of Regression Slopes in Meta-Analysis. Statistical Science. 2007;22 (3):414–429. doi: 10.1214/07-STS243. http://projecteuclid.org/euclid.ss/1199285041. [CrossRef] [Google Scholar